miércoles, 19 de agosto de 2020

Israel starts clinical trial of plasma-derived Covid drug - ISRAEL21c

Israel starts clinical trial of plasma-derived Covid drug - ISRAEL21c

Israel21c

#AntibodyTreatment

Israel starts clinical trial of plasma-derived Covid drug

12 patients are receiving Kamada’s immunoglobulin for coronavirus disease; so far, three patients were well enough to go home from the hospital.

 AUGUST 13, 2020, 7:57 AM
Abigail Klein Leichman
Abigail Klein Leichman is a writer and associate editor at ISRAEL21c. Prior to moving to Israel in 2007, she was a specialty writer and copy editor at a major daily newspaper in New Jersey and has freelanced for a variety of newspapers and periodicals since 1984.

No hay comentarios:

Publicar un comentario